Category: CareFusion Corp.Syndicate content

Edwards Lifesciences is back in Wall Street's good graces | Medtech Wall Street news for the week of October 6, 2014

October 9, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Wall Street loves Edwards Lifesciences again; Becton Dickinson to buy CareFusion for $12 billion in cash, stock; Proxy war rages on at Echo Therapeutics; Platinum fires back at Echo Therapeutics over 'rogue' directors; Echo Therapeutics hits back at Platinum Equity

Wall Street loves Edwards Lifesciences again

October 3, 2014 by Brian Johnson

Edwards: Medtronic TAVI settlement boosts bottom line in Q2

AdvaMed in the age of consolidation

October 6, 2014 by Brian Johnson

What does news of yet another mega-merger mean for medtech's industry council?

regular_avm14_press_conference_photo.jpg

The winds of change in medtech are blowing in the Windy City.

As medtech's best & brightest descended on Chicago for another annual confab at AdvaMed 2014, it was impossible to ignore that the industry has now entered the great age of consolidation with yet another multibillion-dollar healthcare deal.

Becton Dickinson to buy CareFusion for $12 billion in cash, stock

October 6, 2014 by MassDevice

Becton Dickinson & Co. agrees to pay $12 billion in cash and stock for CareFusion Corp.

Becton Dickinson to buy CareFusion for $12 billion in cash, stock

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ConvaTec said to explore 2015 sale

August 19, 2014 by Brad Perriello

ConvaTec is reportedly weighing a sale of the private-equity-owned medical device company next year, even as interest in a Medtronic-like inversion deal mounts from C.R. Bard, CareFusion and 3M.

ConvaTec said to explore 2015 sale

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FTC wants more data on MDT-COV deal | Medtech Wall Street news for the week of August 11, 2014

August 14, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; Greatbatch acquires Uruguay's CCC Medical Devices; T2 Biosystems IPO raises $57M for MRI-based diagnostics; Strong Q4, $750M buyback give CareFusion a boost; Baxano: Strong Q2, new patents can't appease Wall Street

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried

August 7, 2014 by Arezu Sarvestani

Analyst report: Dems can't stop Medtronic-Covidien merger

Strong Q4, $750M buyback give CareFusion a boost

August 8, 2014 by Arezu Sarvestani

CareFusion gains a couple points after posting a Street-beating 4th quarter and announcing a $750 million share repurchase program.

Strong Q2, $750M buyback give CareFusion a boost

CareFusion (NYSE:CFN) posted a stellar 4th-quarter, posting double-digit growth in revenues and earnings and beating Wall Street's estimates.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

UPDATE: FDA warns CareFusion over modified devices, quality control

July 24, 2014 by Brad Perriello

The FDA wants CareFusion to stop selling its anesthesia breathing circuit and the Denver ascites shunt and percutaneous access kit until it applies for clearance for changes made to the devices and clears up some quality control issues at a plant in Illinois.

FDA warns CareFusion over modified devices, quality control

UPDATED July 24, 2014, with comment from CareFusion.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp